According to FibroGen's latest financial reports the company has a price-to-book ratio of 0.395156.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | -0.2898 | -46.08% |
2023-12-31 | -0.5374 | -99.95% |
2022-12-31 | < -1000 | -17925.33% |
2021-12-31 | 5.71 | -25.38% |
2020-12-31 | 7.65 | 8.9% |
2019-12-31 | 7.02 | -6.14% |
2018-12-31 | 7.48 | 5.18% |
2017-12-31 | 7.11 | -7.85% |
2016-12-31 | 7.72 | -19.56% |
2015-12-31 | 9.60 | 43.06% |
2014-12-31 | 6.71 | |
2013-12-31 | N/A |